financetom
Business
financetom
/
Business
/
Nike Stock Is Tumbling Thursday: Here's Why
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nike Stock Is Tumbling Thursday: Here's Why
Apr 3, 2025 7:56 AM

Nike Inc ( NKE ) shares are tumbling Thursday after U.S. President Donald Trump announced sweeping reciprocal tariffs on several countries around the world.

What To Know: Nike ( NKE ) shares are falling sharply Thursday morning as Trump administration tariffs threaten the company’s supply chain.

Nike ( NKE ) imports most of its products from Vietnam, China and Indonesia. Close to 50% of all Nike ( NKE ) footwear is currently made in Vietnam, according to Bloomberg.

The Trump administration announced new 46% reciprocal tariffs on Vietnam, 34% tariffs on China and 32% tariffs on Indonesia late Wednesday, sending stock market futures spiraling lower. Retailers are among the hardest hit names.

Nike ( NKE ) competitor, Adidas is facing selling pressure as it makes about 39% of its footwear in Vietnam. Lululemon is also trading significantly lower Thursday morning. The athleisure company makes 40% of its products in Vietnam and about 17% in Cambodia. Trump slapped a 49% reciprocal tariff on Cambodia this week.

Wedbush’s Dan Ives took to X following the announcement, calling the tariffs “worse than the worst case scenario.”

“The biggest focus will be the China 34% tariff and Taiwan 32% and how this impacts supply chain and demand,” Ives said in the X post.

NKE Price Action: Nike ( NKE ) shares were down 13.0% at $56.51 at the time of publication Thursday, according to Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Take Two Interactive Software Insider Sold Shares Worth $5,113,298, According to a Recent SEC Filing
Take Two Interactive Software Insider Sold Shares Worth $5,113,298, According to a Recent SEC Filing
Aug 22, 2025
04:58 PM EDT, 08/22/2025 (MT Newswires) -- Daniel P Emerson, Chief Legal Officer, on August 21, 2025, sold 22,479 shares in Take Two Interactive Software ( TTWO ) for $5,113,298. Following the Form 4 filing with the SEC, Emerson has control over a total of 129,792 common shares of the company, with 129,792 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/946581/000094658125000005/xslF345X05/form4.xml ...
Atlassian Insider Sold Shares Worth $1,259,377, According to a Recent SEC Filing
Atlassian Insider Sold Shares Worth $1,259,377, According to a Recent SEC Filing
Aug 22, 2025
04:59 PM EDT, 08/22/2025 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, CEO, Co-Founder, on August 21, 2025, sold 7,665 shares in Atlassian ( TEAM ) for $1,259,377. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 206,955 Class A common shares of the company, with 206,955 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218025005957/xslF345X05/primarydocument.xml ...
Atlassian Insider Sold Shares Worth $1,259,377, According to a Recent SEC Filing
Atlassian Insider Sold Shares Worth $1,259,377, According to a Recent SEC Filing
Aug 22, 2025
04:59 PM EDT, 08/22/2025 (MT Newswires) -- Scott Farquhar, 10% Owner, Director, on August 21, 2025, sold 7,665 shares in Atlassian ( TEAM ) for $1,259,377. Following the Form 4 filing with the SEC, Farquhar has control over a total of 206,955 Class A common shares of the company, with 206,955 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218025005958/xslF345X05/primarydocument.xml ...
Devonian Health Group Provides Updates On Business and Previously Announced Private Placement
Devonian Health Group Provides Updates On Business and Previously Announced Private Placement
Aug 22, 2025
04:59 PM EDT, 08/22/2025 (MT Newswires) -- Devonian Health Group ( DVHGF ) , a clinical-stage corporation focused on developing unique solutions to inflammatory diseases, provided a corporate update and additional information on a previously announced private placement after-hours on Friday. On the manufacturing front, the Thykamine batch-to-batch consistency has been validated through advanced analytical techniques, and pre-clinical programs are...
Copyright 2023-2026 - www.financetom.com All Rights Reserved